February 01, 2013 at 09:35 AM EST
Perrigo Q2 Profit Rises; Adjusted Net and Revenue Beat Wall Street View (PRGO)

On Friday drug company Perrigo (PGRO) said that it saw a 6% increase to its second quarter earnings on higher revenues, with adjusted net income and revenue beating Wall Street expectations.

The Allegan, Michigan-based company reported a fiscal second quarter net income of $105.95 million, or $1.12 per share, up from $99.74 million, or $1.06 per share, earned in the same quarter a year earlier. Adjusted earnings increased to $1.36 per share from $1.20. Analysts, according to Thomson Reuters, were expecting EPS to be $1.31.

The company’s net sales were up to $882.96 million from $838.17 million last year. This just beat the analyst estimate of $881.84 million in revenue for the quarter.

Also announced on Friday was that Perrigo signed a agreement to acquire leading pet health product company Velcera for $160 million in cash.

Looking ahead to fiscal 2013, the company is expecting EPS to be between $5.45 and $5.65 while analysts foresee EPS at $5.54.

Perrigo shares were up $4.99, or +4.96%, during pre-market trading on Friday. The stock is up +4.59% over the past year.

The Bottom Line
Shares of Perrigo (PRGO) have a dividend yield of 0.36% based on last night’s closing price of $100.51.

Perrigo Company (PRGO) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here